Maarten Kraan, MD, PhD (he/him/his)

CDS Advies BV
Den Dolder, Netherlands

Rheumatologist, PhD in translational science

Presentation(s):

• 0493: Phase I Trial in Participants with Rheumatoid Arthritis and Healthy Volunteers with CIT-013, a First in Class NETosis Inhibitor

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Citryll BV: Consultant (Ongoing)